lower cholesterol
Natural health product licensed in Canada
- Licence holder
- Company 123
- NPN or DIN-HM
- 80041618
- Status
- Active licence
- Licence date
- 11 April 2013
- Revision date
- 14 December 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glucomannane Source : Amorphophallus konjac - tubercule | 500 mg | Not calculated |
| Glucomannane Source : Glucomannan | 500 mg | Not calculated |
| Coffea arabica Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1,550 mg Potency : 50 % Chlorogenic acids | 62 mg | Not calculated |
| Coffea arabica Source : Graine(s) Potency : 5 % Caffeine | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Silice, Gélatine, Hydroxypropylcellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 days |
Uses authorised in Canada
Glucomannan helps to lower cholesterol levels (by reducing cholesterol absorption from the gastrointestinal tract). Glucomannan promotes bowel movements by increasing bulk volume and water content. Glucomannan provides gentle relief of constipation and/or irregularity. Coffea arabica provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within 7 days. Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consult a health care practitioner prior to use if have a history of cancer; a cardiovascular disorder, diabetes, hypercholesteremia, hyperthyroidism, or a kidney disorder. Consult a health care practitioner prior to use if you are taking antihistamines or hypotensive drugs. Consult a health care practitioner prior to use if you have been treated for or diagnosed with, of have a family history of any medical condition including (but not limited to) liver disease, or if you are using any prescription or over-the-counter drug.
Source
Official Health Canada record, licence 80041618
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging